Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTXinGCA: Methotrexate for Remission Maintenance in Giant Cell Arteritis
NCT05623592Phase 2Active, not recruiting
- Sponsor
- University of Bonn
- Start
- Nov 2022
- Primary completion
- Nov 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in giant cell arteritis (GCA), sponsored by University of Bonn. Started Nov 2022; status: active, not recruiting.
02
Drugs
methotrexate
03
Conditions
giant cell arteritis (GCA)
Beyond the preview
Go deeper on NCT05623592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05623592.